These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 20015155)

  • 21. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of peptide and protein drugs over the blood-brain barrier.
    Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
    Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
    Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
    Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.
    Teixidó M; Zurita E; Malakoutikhah M; Tarragó T; Giralt E
    J Am Chem Soc; 2007 Sep; 129(38):11802-13. PubMed ID: 17764181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of the blood-brain barrier.
    Engelhardt B
    Cell Tissue Res; 2003 Oct; 314(1):119-29. PubMed ID: 12955493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of blood-brain and blood-cerebrospinal fluid barrier (author's transl)].
    Wakai S
    No To Shinkei; 1981 Nov; 33(11):1077-92. PubMed ID: 7037021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses.
    Deeken JF; Löscher W
    Clin Cancer Res; 2007 Mar; 13(6):1663-74. PubMed ID: 17363519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and function of the blood-brain barrier.
    Abbott NJ; Patabendige AA; Dolman DE; Yusof SR; Begley DJ
    Neurobiol Dis; 2010 Jan; 37(1):13-25. PubMed ID: 19664713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound, microbubbles and the blood-brain barrier.
    Meairs S; Alonso A
    Prog Biophys Mol Biol; 2007; 93(1-3):354-62. PubMed ID: 16959303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum proteins bypass the blood-brain fluid barriers for extracellular entry to the central nervous system.
    Broadwell RD; Sofroniew MV
    Exp Neurol; 1993 Apr; 120(2):245-63. PubMed ID: 8491281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of transport inhibitors and additional anti-HIV drugs on the movement of lamivudine (3TC) across the guinea pig brain barriers.
    Gibbs JE; Rashid T; Thomas SA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1035-41. PubMed ID: 12766261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier.
    Zlokovic BV; Jovanovic S; Miao W; Samara S; Verma S; Farrell CL
    Endocrinology; 2000 Apr; 141(4):1434-41. PubMed ID: 10746647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
    Reichel A; Begley DJ; Abbott NJ
    J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cerebrospinal fluid and barriers - anatomic and physiologic considerations.
    Tumani H; Huss A; Bachhuber F
    Handb Clin Neurol; 2017; 146():21-32. PubMed ID: 29110772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in quantitative proteomics as a sensitive tool to quantify drug transporters and drug metabolizing enzymes at the human blood-brain barrier].
    Jacob A; Declèves X; Scherrmann JM
    Biol Aujourdhui; 2012; 206(3):177-83. PubMed ID: 23171840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.
    Engelhardt B; Sorokin L
    Semin Immunopathol; 2009 Nov; 31(4):497-511. PubMed ID: 19779720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.